Select Publications
Journal articles
2011, 'The influence of HLA supertype on thymidine analogue induced body composition changes in STEAL', ANTIVIRAL THERAPY, 16, pp. A20 - A21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Alterations in Immune Function are Associated with Liver Enzyme Elevation in HIV and HCV Co-infection after Commencement of Combination Antiretroviral Therapy', Journal of Clinical Immunology, 31, pp. 1079 - 1083, http://dx.doi.org/10.1007/s10875-011-9587-6
,2011, 'Combination antiretroviral therapy as treatment for HIV-associated MALT lymphoma of the nasopharynx', Internal Medicine Journal, 41, pp. 437 - 438
,2011, 'Community-acquired Klebsiella pneumoniae liver abscess - an "emerging disease" in Australia', Medical Journal of Australia, 194, pp. 374 - 374
,2011, 'Does aminoglycoside therapy cause significant acute kidney injury in febrile neutropenia?', International Journal of Antimicrobial Agents, 37, pp. 78 - 81, http://dx.doi.org/10.1016/j.ijantimicag.2010.08.017
,2011, 'Improvement in chronic renal failure following the discontinuation of tenofovir in two HIV-infected patients', Nephrology, 16, pp. 453 - 455
,2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, 204, pp. 1532 - 1540, http://jid.oxfordjournals.org/content/204/10/1532
,2011, 'Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection', Journal of Medical Virology, 83, pp. 1406 - 1409, http://dx.doi.org/10.1002/jmv.22109
,2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, 6, pp. Article number e26885, http://dx.doi.org/10.1371/journal.pone.0026885
,2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, 24, pp. 2657 - 2663
,2010, 'Acute hepatitis B virus infection despite previous immunisation in the context of recent HIV-1 infection', AIDS, 24, pp. 2137 - 2138
,2010, 'Immunisation and multi-dose vials', Vaccine, 28, pp. 6556 - 6561, http://dx.doi.org/10.1016/j.vaccine.2010.07.052
,2010, 'Late diagnosis of human immunodeficiency virus (HIV) in two patients previously treated for pulmonary tuberculosis - a missed opportunity for an earlier HIV diagnosis?', Internal Medicine Journal, 40, pp. e2 - e3, http://dx.doi.org/10.1111/j.1445-5994.2010.02376.x
,2010, 'Self-reported HIV testing practice among physicians treating tuberculosis in Australia and New Zealand', International Journal of STD and AIDS, 21, pp. 346 - 350
,2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A289 - A289, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Health care-associated native valve endocarditis: Importance of non-nosocomial acquisition', Annals of Internal Medicine, 150, pp. 586 - 594, http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00004
,2009, 'Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century The international collaboration on Endocarditis-prospective cohort study', Archives of Internal Medicine, 169, pp. 463 - 473, http://dx.doi.org/10.1001/archinternmed.2008.603
,2009, 'A delayed hypersensitivity reaction to enfuvirtide after rechallenge', International Journal of STD and AIDS, 20, pp. 288 - 289
,2009, 'Coagulase-negative staphylococcal prosthetic valve endocarditis-a contemporary update based on the International Collaboration on Endocarditis: Prospective cohort study', Heart, 95, pp. 570 - 576
,2009, 'Immunological determinants of the outcomes from primary hepatitis C infection', CMLS - Cellular and Molecular Life Sciences, 66, pp. 733 - 756
,2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, 10, pp. 163 - 172
,2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, 49, pp. 1591 - 1601
,2008, 'Current features of infective endocarditis in elderly patients: Results of the international collaboration on endocarditis prospective cohort study', Archives of Internal Medicine, 168, pp. 2095 - 2103, http://dx.doi.org/10.1001/archinte.168.19.2095
,2008, 'Phylogenetic analysis of viridans group streptococci causing endocarditis', Journal of Clinical Microbiology, 46, pp. 3087 - 3090, http://dx.doi.org/10.1128/JCM.00920-08
,2008, 'Candida infective endocarditis', European Journal of Clinical Microbiology and Infectious Diseases, 27, pp. 519 - 529, http://dx.doi.org/10.1007/s10096-008-0466-x
,2008, 'Leptotrichia endocarditis: Report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases', European Journal of Clinical Microbiology and Infectious Diseases, 27, pp. 139 - 143, http://dx.doi.org/10.1007/s10096-007-0406-1
,2008, 'To routinely offer testing for HIV infection in all cases of tuberculosis: a rational clinical approach?', Medical Journal of Australia, 188, pp. 162 - 163
,2007, 'Non-HACEK gram-negative bacillus endocarditis', Annals of Internal Medicine, 147, pp. 829 - 835, http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00002
,2007, 'Reply [6]', Internal Medicine Journal, 37, pp. 510, http://dx.doi.org/10.1111/j.1445-5994.2007.01418.x
,2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589
,2007, 'Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection', Immunology and Cell Biology, 85, pp. 24 - 32
,2007, 'Management of infected pacemakers and implantable cardioverter-defibrillators - Reply', Internal Medicine Journal, 37, pp. 510 - 510
,2007, 'Munchausen syndrome by proxy and recurrent polymicrobial bacteremia', Pediatric Infectious Disease Journal, 26, pp. 191 - 191
,2006, 'Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study', HIV Medicine, 7, pp. 544 - 548
,2006, 'Outcome after complete percutaneous removal of infected pacemaker systems and implantable cardiac defibrillators', Internal Medicine Journal, 36, pp. 790 - 792
,2005, 'Loss of CCR5+ T cells in the liver of HCV infected individuals co-infected with HIV', Tissue Antigens, 66, pp. 437 - 438
,2005, 'New developments in antiretroviral therapy for HIV infection', Australian Prescriber, 28, pp. 146 - 148
,2004, 'Community-acquired MRSA epiduritis in an Australian prison inmate [2]', Medical Journal of Australia, 180, pp. 650 - 651, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06134.x
,2004, 'An unusual cause of an epidural abscess', Medical Journal of Australia, 180, pp. 40 - 41
,2004, 'Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort', Journal of Infectious Diseases, 189, pp. 1846 - 1855
,2004, 'Community acquired methicillin resistant Staphylococcus aureus epiduritis in an Australian prison inmate', Medical Journal of Australia, 180, pp. 650 - 651
,2004, 'Prevalence of Production of Virus-Specific Interferon- among Seronegative Hepatitis C-Resistant Subjects Reporting Injection Drug Use', Journal of Infectious Diseases, 190, pp. 1093 - 1097
,2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129
,2004, 'Virus-specific cellular immunity is prevalent among hepatitis C-resistant injecting drug users', Journal of Infectious Diseases, 190, pp. 1093 - 1097
,2003, 'Acute hepatitis C', Australian Family Physician, 32, pp. 804 - 806
,2003, 'Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation', Journal of Leukocyte Biology, 74, pp. 360 - 369
,2003, 'Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-sharing in Australian prisons', Medical Journal of Australia, 178, pp. 546 - 549
,2003, 'The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection', Journal of Hepatology, 38, pp. 349 - 356
,2002, 'Bone mineral density abnormalities in patients with hiv infection [2]', Journal of Acquired Immune Deficiency Syndromes, 30, pp. 131 - 132, http://dx.doi.org/10.1097/00126334-200205010-00020
,2002, '. Immunity against hepatitis C virus infection', Lancet, 360, pp. 1019 - 1020
,